Thursday, 30/04/2026 · 15:00
London (GMT +1:00)
Cost: Free
Add to calendar
Ali Landman
Editor-in-Chief, The Lancet Medical Imaging & Theranostics, UK
Ali Landman became the founding Editor-in-Chief of The Lancet Medical Imaging & Theranostics in January, 2026. Ali began her editorial career as a Senior Editor at The Lancet Oncology in 2015, moving to Deputy Editor in March, 2019, and spent a year as Acting Editor-in-Chief of The Lancet Child & Adolescent Health (2024-2025). She earned her PhD in Cancer Biology at the Massachusetts Institute of Technology (Cambridge, MA, USA) and undertook post-doctoral research in translational oncology and in neurodegenerative disease at the University of California (San Francisco, CA, USA), University College London (London, UK), and the Medical Research Council (Harwell, UK) before joining The Lancet Group. Ali has a special interest in tumour imaging, theranostics, access to care, and health equity.
Pierre Nauleau
Deputy Editor, The Lancet Medical Imaging & Theranostics, USA
Before becoming Deputy Editor of The Lancet Medical Imaging & Theranostics, Pierre Nauleau was a Senior Editor for eBioMedicine (2020-2023) and then an Agile Senior Editor for various journals of The Lancet Group (2024-2025). After a Master's degree in Medical Imaging at Ecole Normale Cachan - Université Paris-Saclay (Paris, France), Pierre completed his PhD in Acoustics at Sorbonne Université (Paris, France) developing ultrasonic methods of characterisation of bone properties in 2013. He then conducted post-doctoral research at Columbia University (New York, NY, USA) focused on ultrasound elasticity imaging applied to cardiovascular diseases. In addition to these topics, Pierre is also interested in the environmental sustainability aspects of medical imaging.
Ankita Das
Senior Editor, The Lancet Medical Imaging & Theranostics, UK
Before joining The Lancet Medical Imaging & Theranostics as Senior Editor, Ankita Das conducted post-doctoral research at Queen Mary University of London (London, UK; 2025) and Newcastle University (Newcastle-upon-Tyne, UK; 2024), working in translational cardiovascular science and biomarker discovery. Ankita holds a PhD in Biological Sciences and Bioengineering from the Indian Institute of Technology (Kanpur, India), with prior training in biomedical engineering. Her professional interests lie at the intersection of medical imaging, diagnostics, and translational research within high-impact clinical publishing.